The global Acute Conjunctivitis Market is expected to witness significant revenue growth during the forecast period. The market is driven by various factors, including the increase in sedentary lifestyle habits, the emergence of new allergens, the rise in contact lens usage, and the growing number of eye procedures.
Acute conjunctivitis is a condition that can affect one or both eyes, causing inflammation in the conjunctiva, the nerves, and the small blood vessels. This inflammation can be caused by bacteria, germs, viruses, or fungi, affecting the inner eyelids, the thin and moist membrane lining the outer eye, and the cornea. Symptoms of eye infections include redness, pain, light sensitivity, watery eyes, swelling around the eyes, itching, hazy vision, swollen eyes, and dry eyes.
Get a free sample PDF of the report, visit @ https://www.reportsanddata.com/download-free-sample/5364
There are several factors driving the growth of the acute conjunctivitis market. One of the major drivers is the increased prevalence of eye infections. According to the World Health Organization (WHO), as of June 2021, approximately 136 million people live in trachoma-endemic areas and are at risk of developing trachoma, a bacterial infection caused by chlamydia trachomatis that affects the eyes. Other factors contributing to the demand for acute conjunctivitis treatment include the rise in sedentary lifestyle, the emergence of new allergens, the increased use of contact lenses, and the need for pink eye therapy.
However, there are certain restraints that hinder the growth of the acute conjunctivitis market. The side effects associated with the use of corticosteroid eye infection treatments, such as irritability, anemia, headaches, diarrhea, and itching, pose a significant challenge. In some cases, these treatments can also cause damage to the kidneys and liver. Additionally, the high capital expenditures required for the development of new therapeutics for acute conjunctivitis and the stringent regulations and time-consuming drug approval process also impede market growth.
Nevertheless, there are opportunities for growth in the acute conjunctivitis industry. Rising technological advancements, groundbreaking innovations, government-supported awareness campaigns, and ongoing research and development efforts to introduce new treatments are some of the factors that offer future growth opportunities for key players in the market.
In terms of market share, the North America region holds the largest share and is expected to register the highest revenue growth during the forecast period. This can be attributed to the region’s growing elderly population, increased focus on healthcare infrastructure, easy access to eye care, and extensive use of contact lenses. The market in the Asia Pacific region is projected to grow at the fastest rate, driven by the demand for eye treatments, increasing healthcare systems, and a surge in research and development expenditures by key players. Countries like India and China, with their dense populations and expanding healthcare systems, provide a promising environment for the treatment of acute conjunctivitis.
To know more about the latest insights of the report, visit @
https://www.reportsanddata.com/request-latest-insight/5364
Our report provides comprehensive insights into the acute conjunctivitis market. It includes historical data, forecasts, and revenue growth at a global, regional, and country level. The report analyzes industry trends, consumption patterns, and provides detailed information for each region, major country, and segment from 2019 to 2030. It covers drivers, restraints, opportunities, threats, market strategies, segment revenue, and the revenue share contribution of each regional and country market. Additionally, the report offers industry analysis, competitive landscape, company financials, and impact analysis.
Key market trends and innovations include the development of new treatments, particularly biologics. For example, in June 2022, Aldeyra announced the success of reproxalap, an investigational novel medication candidate for the treatment of dry eye condition, in a Phase 3 clinical study. Clinical trials are also being conducted on biologic 10.000 MM09 to understand its safety and efficacy in patients suffering from acute conjunctivitis.
Several organic and inorganic strategies have been adopted by companies in the market. For instance, in January 2022, Laboratories Théa SAS signed a deal with Akorn Operating Company LLC. to expand its presence in the U.S. eye care sector. In October 2021, the U.S. Food and Drug Administration (FDA) approved TYRVAYA Nasal Spray for the management of dry eye disease symptoms and signs. Furthermore, major companies in the acute conjunctivitis market include Merck & Co., Inc., Mylan N.V., Teva Pharmaceutical Industries Ltd., Eyevance Pharmaceuticals LLC, Pfizer Inc., Sanofi S.A., GlaxoSmithKline plc, Intas Pharmaceuticals Ltd., Johnson & Johnson Services Inc., Allergan plc., Macleods Pharmaceuticals Ltd., Alcon Laboratories Inc., and Bausch Health Companies Inc. Notable start-ups and key innovative players in the market include Ocuphire Pharma and Visus Therapeutics.
The report covers various aspects of the market, including disease types (acute conjunctivitis and chronic conjunctivitis), causes (bacteria, virus, and allergies), drug types (corticosteroids, quinolone antibiotics, macrolide antibiotics, tetracycline antibiotics, polyene antifungals, and aminoglycoside antibiotics), distribution channels (online and offline), end-users (hospital pharmacy, retail pharmacy, and specialty clinics), and regional outlook (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa).
Request a customized copy of the report @ https://www.reportsanddata.com/request-customization-form/5364
Thank you for reading our report. To inquire about customization or any query about the report, please get in touch with us. Our team will make sure the report is best suited to your needs.
Browse for more reports:
In-Vitro Diagnostics (IVD) Quality Control Market
Insulin Delivery Devices Market
Healthcare Adhesive Tapes Market
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
(Head of Business Development)
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Blogs | Press Release | Industry News | Our competencies
Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports
Browse More Latest Reports @ https://www.reportsanddata.com/report